Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Lea Christian
Observed name:
L.R. Christian
Institutions:
City Of Hope National Medical Center,
City of Hope,
Beckman Research Institute,
Western University of Health Sciences
Observed institutions:
City Of Hope National Medical Center,
Wright State University,
City of Hope,
Beckman Research Institute,
Western University of Health Sciences
ORCID:
0000-0001-6895-4765
Observed ORCID:
0000-0001-6895-4765
OpenAlex ID:
A5026771990
Antigen-dependent IL-12 signaling in CAR T cells promotes regional to systemic disease targeting
2023
·
Eric Hee Jun Lee
, John P. Murad
, et al.
·
Nature Communications
·
131
PDF
Solid tumour CAR-T cells engineered with fusion proteins targeting PD-L1 for localized IL-12 delivery
2025
·
John P. Murad
, Lea Christian
, et al.
·
Nature Biomedical Engineering
·
68
PDF
New concepts on abnormal UV reactions in systemic lupus erythematosus and a screening tool for assessment of photosensitivity
2023
·
Danielle Corbin
, Lea Christian
, et al.
·
Skin Research and Technology
·
20
PDF
Evidence for Systemic Reactive Oxygen Species in UVB‐mediated Microvesicle Formation
2021
·
Cameron L. McGlone
, Lea Christian
, et al.
·
Photochemistry and Photobiology
·
8
Evidence for the involvement of keratinocyte‐derived microvesicle particles in the photosensitivity associated with xeroderma pigmentosum type A deficiency
2024
·
Lea Christian
, Pranali Manjrekar
, et al.
·
Photochemistry and Photobiology
·
3
PDF
Abstract 6676: Microbiome modification impacts PSCA directed chimeric antigen receptor (CAR) T cell therapy for prostate cancer
2024
·
John Paul Murad
, Lea Christian
, et al.
·
Cancer Research
·
2
309 Combining radiopharmaceutical therapy with CAR T cells to overcome the heterogeneous immunosuppressive prostate tumor microenvironment
2025
·
Jiangyue Liu
, Yuwei Ren
, et al.
·
Journal for ImmunoTherapy of Cancer
·
1
PDF
644 Combining radiopharmaceutical ligand therapy with CAR T cells to overcome the heterogeneous immunosuppressive prostate tumor microenvironment
2026
·
Jiangyue Liu
, John P Murad
, et al.
·
Journal for ImmunoTherapy of Cancer
PDF
Radioligand therapy in combination with CAR T cells overcomes the heterogeneous immunosuppressive prostate tumor microenvironment
2026
·
Jiangyue Liu
, Iveta Fajnorova
, et al.
·
bioRxiv (Cold Spring Harbor Laboratory)
Focal radiotherapy improves CAR T cell therapy targeting prostate cancer
2026
·
Cari A. Young
, Jiangyue Liu
, et al.
·
bioRxiv (Cold Spring Harbor Laboratory)
Abstract 3996: Secreted cytokine-αPDL1 fusion proteins improve solid tumor chimeric antigen receptor (CAR) T-cell therapy
2024
·
Lea Christian
, John P. Murad
, et al.
·
Cancer Research
Abstract 4090: Regional administration of IL-12 endowed CAR T cells effectively targets systemic disease
2023
·
Hee Jun Lee
, Yuki Yamaguchi
, et al.
·
Cancer Research
506 Xeroderma Pigmentosum A deficiency results in increased generation of microvesicle particles in response to Ultraviolet B Radiation
2021
·
L.R. Christian
, C.E. Borchers
, et al.
·
Journal of Investigative Dermatology
Show more works
View as search
Works count:
13
Citation count:
233
H-index:
4
I10-index:
3
Year
Topic
Type